U.S. Cell Culture Market Size & Outlook, 2026-2033
- Biotechnology
- Cell Culture & Stem Cell
- Cell Culture Market Outlook
- Cell Culture & Stem Cell
Global Market
Related Markets
Ask a question about the cell culture market
U.S. cell culture market highlights
- The U.S. cell culture market generated a revenue of USD 6,007.1 million in 2025 and is expected to reach USD 14,180.3 million by 2033.
- The U.S. market is expected to grow at a CAGR of 11.6% from 2026 to 2033.
- In terms of segment, consumables was the largest revenue generating product in 2025.
- Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
Cell culture market data book summary
| Market revenue in 2025 | USD 6,007.1 million |
| Market revenue in 2033 | USD 14,180.3 million |
| Growth rate | 11.6% (CAGR from 2026 to 2033) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Consumables, Instruments |
| Key market players worldwide | Sartorius AG, Danaher Corp, Merck KGaA, Thermo Fisher Scientific Inc, Corning Inc, Avantor Inc, BD, Eppendorf, Bio-Techne Corp, PromoCell GmbH |
Other key industry trends
- In terms of revenue, U.S. accounted for 31.4% of the global cell culture market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. cell culture market is projected to lead the regional market in terms of revenue in 2033.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 14,180.3 million by 2033.
The U.S. market for cell culture is expected to witness lucrative growth as it is the biggest market for biotechnology & biopharmaceuticals and a leader in biopharmaceutical R&D. According to data published by PhRMA in 2018, the U.S. biopharmaceutical industry invested around USD 102 billion in R&D activities. Furthermore, the high prevalence of chronic diseases, such as cancer, and extensive R&D activities by regional players to develop novel cell & gene therapies are expected to fuel the demand for cell culture solutions.
As per the American Cancer Society’s estimates, in 2021, around 1.9 million new cases of cancer were estimated to be diagnosed in the U.S., with over 608,570 cancer related deaths. In addition, following the outbreak of COVID‐19, several U.S.-based companies were involved in extensive research for the development of novel vaccines & therapeutics, driving the demand for cell culture solutions for various research applications.
In addition, the local presence of major players like Thermo Fisher Scientific, BD, & Danaher in the country and strategic initiatives undertaken by key players are anticipated to fuel the market growth. For instance, in November 2022, Fujifilm announced an investment of USD 188 million to construct a cell culture media manufacturing plant in North Carolina.
No credit card required*
Publish Date: Apr 29, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cell Culture Market Scope
Cell Culture Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Sartorius AG | View profile | 14,338 | Otto-Brenner-Strasse 20, Gottingen, NI, Germany, 37079 | www.sartorius.com |
| Avantor Inc | View profile | 14,500 | 100 Matsonford Road, Suite 200, Building One, Radnor Corporate Center, Radnor, PA, United States, 19087 | www.avantorsciences.com |
| Bio-Techne Corp | View profile | 3,050 | 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 | www.bio-techne.com |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | www.bd.com |
| Corning Inc | View profile | 49,800 | One Riverfront Plaza, Corning, NY, United States, 14831 | www.corning.com |
| PromoCell GmbH | View profile | 51-100 | Heidelberg, Baden-Wurttemberg, Germany, Europe | www.promocell.com/ |
| Eppendorf | View profile | 1001-5000 | Hamburg, Hamburg, Germany, Europe | dasgip.de |
U.S. Cell Culture Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Cell Culture Market Outlook will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 64.44% in 2025.
Horizon Databook has segmented the U.S. cell culture market based on consumables, instruments covering the revenue growth of each sub-segment from 2021 to 2033.
The U.S. market for cell culture is expected to witness lucrative growth as it is the biggest market for biotechnology & biopharmaceuticals and a leader in biopharmaceutical R&D. According to data published by PhRMA in 2018, the U.S. biopharmaceutical industry invested around USD 102 billion in R&D activities. Furthermore, the high prevalence of chronic diseases, such as cancer, and extensive R&D activities by regional players to develop novel cell & gene therapies are expected to fuel the demand for cell culture solutions.
As per the American Cancer Society’s estimates, in 2021, around 1.9 million new cases of cancer were estimated to be diagnosed in the U.S., with over 608,570 cancer related deaths. In addition, following the outbreak of COVID‐19, several U.S.-based companies were involved in extensive research for the development of novel vaccines & therapeutics, driving the demand for cell culture solutions for various research applications.
In addition, the local presence of major players like Thermo Fisher Scientific, BD, & Danaher in the country and strategic initiatives undertaken by key players are anticipated to fuel the market growth. For instance, in November 2022, Fujifilm announced an investment of USD 188 million to construct a cell culture media manufacturing plant in North Carolina.
- U.S. Cell Culture Market Product Outlook (Revenue, USD Million , 2021-2033)
- Consumables
- Instruments
- U.S. Cell Culture Market Application Outlook (Revenue, USD Million , 2021-2033)
- Biopharmaceutical Production
- Drug Development
- Diagnostics
- Tissue Culture & Engineering
- Cell and Gene Therapy
- Toxicity Testing
- Other Applications
Reasons to subscribe to Cell Culture Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Cell Culture Market Outlook databook
- Our clientele includes a mix of Cell Culture Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. Cell Culture Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. Cell Culture Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
U.S. Cell Culture Market, 2021-2033 (US$M)
U.S. cell culture market statistics, by product, 2021-2033 (US$M)
